EDAP Announces Pricing of Public Offering of American Depositary Shares
LYON, France, September 22, 2022 — EDAP TMS S.A. (NASDAQ:EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its public offering of its American Depositary Shares (“ADSs”), which commenced on September 22, 2022, has been set today at $7.50 per ADS, before underwriting discounts and commissions, and that the number of offered ADSs is 2,666,667. In addition, Jefferies LLC has been granted a 30-day over-allotment option to purchase up to an additional 400,000 ADSs on the same terms and conditions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by the Company, are expected to be approximately $20,000,003. The closing of the offering is expected to occur on September 27, 2022, subject to customary closing conditions.
Related news for (EDAP)
- EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
- EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
- EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
- EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
- EDAP Announces First Quarter 2023 Financial Results